A Randomized, Double Blind, Placebo-controlled Study to Assess the the Preemptive Benefit of Etoricoxib in Patients Receiving Anterior Cruciate Ligament Reconstruction
Clinical trial NCT00554346 · COMPLETED
Trial details
- NCT number
- NCT00554346
- Sponsor
- National Taiwan University Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-06-01
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.